Peter Tai-Ching Ho is Chief Development Officer at Epizyme, Inc. (EPZM). They have made 14 open-market trades across 1 company since 2014, most recently 2022-10-24.
CIK 0001619052
7 open-market purchases totalling $84K since 2014, against 7 sales. Across 7 scored buys the stock is down 5.0% at ninety days, and 5.9 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 14% | 14% |
| Avg Move | -29.6% | -3.1% | -5.0% |
| Alpha | -24.8% | -3.3% | -5.9% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPZM | SELL | 2017-10-24 | 2017-10-25 | $16.44 | $493K | -10.7% | -25.4% | +3.1% |
| EPZM | SELL | 2017-09-25 | 2017-09-26 | $16.81 | $504K | +12.1% | -3.0% | -22.4% |
| EPZM | SELL | 2017-08-24 | 2017-08-28 | $15.68 | $235K | +14.4% | +5.8% | -26.4% |
| EPZM | SELL | 2017-07-24 | 2017-07-26 | $13.44 | $202K | +10.1% | +33.6% | +30.4% |
| EPZM | SELL | 2017-06-26 | 2017-06-27 | $14.87 | $223K | +0.0% | -14.5% | +14.2% |
| EPZM | SELL | 2017-05-25 | 2017-05-26 | $16.11 | $242K | -26.6% | -8.3% | +2.2% |
| EPZM | SELL | 2016-12-08 | 2016-12-12 | $10.89 | $2K | +1.3% | -0.4% | +44.2% |
| EPZM | BUY | 2016-02-29 | 2016-03-02 | $7.47 | $5K | +16.9% | +25.3% | +16.5% |
| EPZM | BUY | 2015-12-09 | 2015-12-10 | $14.69 | $15K | -37.3% | -34.9% | -39.3% |
| EPZM | BUY | 2015-08-31 | 2015-09-02 | $17.00 | $9K | -37.3% | -2.4% | -2.4% |
| EPZM | BUY | 2015-08-20 | 2015-08-24 | $16.51 | $33K | -37.3% | -2.4% | -2.4% |
| EPZM | BUY | 2015-05-05 | 2015-05-06 | $16.36 | $7K | -37.3% | -2.4% | -2.4% |
| EPZM | BUY | 2014-12-16 | 2014-12-18 | $17.63 | $4K | -37.3% | -2.4% | -2.4% |
| EPZM | BUY | 2014-12-02 | 2014-12-04 | $21.17 | $13K | -37.3% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.